Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement

AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement

AstraZeneca has signed a new licencing agreement with UK-based biotechnology company, RQ BIO, for its portfolio of early-stage monoclonal antibodies targeting SARS-CoV-2. ... global player in AstraZeneca.

NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer

NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer AstraZeneca (AZ) has announced that the National Institute for Health and Care Excellence (NICE) has approved the routine use of Imfinzi (durvalumab) within NHS England as a monotherapy to treat locally

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients AstraZeneca (AZ) and Avillion have announced positive phase 3 trial results from the MANDALA study, showing that PT027 – albuterol/budesonide – demonstrated a statistically significant decrease in the risk of a severe ... Mene Pangalos, executive

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca.

AstraZeneca’s Imfinzi plus chemotherapy accepted for Priority Review in the US

AstraZeneca’s Imfinzi plus chemotherapy accepted for Priority Review in the US AstraZeneca’s (AZ) has announced that its treatment, Imfinzi (durvalumab), in combination with chemotherapy, has been accepted and given a Priority Review in the US for patients with locally advanced or

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...